CIBC World Market
MRNA icon

CIBC World Market’s Moderna MRNA Stock Holding History

CIBC World Market’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
16,797
-53,020
-76% -$2.74M ﹤0.01% 984
2026
Q1 		$3.55M Buy
69,817
+60,948
+687% +$2.84M 0.01% 635
2025
Q4 		$262K Sell
8,869
-16,963
-66% -$461K ﹤0.01% 1296
2025
Q3 		$667K Buy
25,832
+700
+3% +$19.5K ﹤0.01% 1037
2025
Q2 		$693K Sell
25,132
-12,871
-34% -$339K ﹤0.01% 965
2025
Q1 		$1.08M Sell
38,003
-15,461
-29% -$549K ﹤0.01% 857
2024
Q4 		$2.22M Sell
53,464
-5,519
-9% -$264K ﹤0.01% 698
2024
Q3 		$3.94M Buy
58,983
+45,522
+338% +$4.18M 0.01% 544
2024
Q2 		$1.6M Sell
13,461
-49,665
-79% -$6.29M ﹤0.01% 690
2024
Q1 		$6.73M Buy
63,126
+34,734
+122% +$3.5M 0.02% 393
2023
Q4 		$2.82M Sell
28,392
-35,335
-55% -$2.97M 0.01% 526
2023
Q3 		$6.58M Sell
63,727
-26,608
-29% -$2.97M 0.02% 317
2023
Q2 		$11M Sell
90,335
-28,713
-24% -$3.83M 0.03% 234
2023
Q1 		$18.3M Buy
119,048
+12,527
+12% +$2.07M 0.06% 179
2022
Q4 		$19.1M Sell
106,521
-15,150
-12% -$2.48M 0.07% 171
2022
Q3 		$14.4M Sell
121,671
-28,438
-19% -$4.32M 0.06% 188
2022
Q2 		$21.4M Sell
150,109
-2,300
-2% -$329K 0.08% 149
2022
Q1 		$26.3M Buy
152,409
+15,055
+11% +$2.53M 0.08% 140
2021
Q4 		$34.9M Sell
137,354
-22,379
-14% -$6.54M 0.1% 130
2021
Q3 		$61.5M Buy
159,733
+42,302
+36% +$15.6M 0.2% 82
2021
Q2 		$27.6M Sell
117,431
-147
-0.1% -$26.3K 0.08% 153
2021
Q1 		$15.4M Buy
117,578
+98,378
+512% +$14.3M 0.04% 196
2020
Q4 		$2.01M Buy
19,200
+13,811
+256% +$1.4M 0.01% 568
2020
Q3 		$381K Sell
5,389
-24,601
-82% -$1.72M ﹤0.01% 898
2020
Q2 		$1.93M Buy
+29,990
New +$1.64M 0.01% 488

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

CIBC World Market's MRNA Position: Q2 2026 in Review

CIBC World Market reduced its Moderna (MRNA) stake by 76% in Q2 2026, selling an estimated $2.74M and leaving 16,797 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #984.

CIBC World Market first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $61.5M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • CIBC World Market held 16,797 shares of Moderna worth $1.18M as of Q2 2026.
  • CIBC World Market sold 53,020 Moderna shares in Q2 2026, an estimated $2.74M.
  • Moderna made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #984 holding.
  • CIBC World Market first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • CIBC World Market's Moderna position peaked at $61.5M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.